CRISPR Therapeutics AG (CRSP) Analyst Estimates Quarterly - Discounting Cash Flows
CRSP
CRISPR Therapeutics AG
CRSP (NASDAQ)
Period Ending: 2026
12-30
2026
09-30
2026
06-30
2026
03-30
2025
12-30
2025
09-30
2025
06-30
2025
03-30
2024
12-30
2024
09-30
2024
06-30
2024
03-30
2023
12-30
2023
09-29
2023
06-29
2023
03-29
2022
12-29
2022
09-29
2022
06-29
2022
03-29
2021
12-29
2021
09-29
2021
06-29
2021
03-29
2020
12-29
2020
09-29
2020
06-29
2020
03-29
2019
12-29
2019
09-29
2019
06-29
2019
03-29
2018
12-29
2018
09-29
2018
06-29
2018
03-29
2017
09-29
2017
06-29
2017
03-29
2016
09-29
Number of Analysts
1234
14 15 19 10 15 15 13 11 18 12 10 10 5 5 5 5 6 6 6 9 10 16 9 10 8 8 11 8 18 17 8 19 18 12 8 15
Estimated Revenue
Low
1234
0.59 1.21 5.99 0.67 0.7 0.761 0.431 1.11 27.74 0.075 0.354 5.09 1.4 0.364 0.436 0.551 0.43 0.241 177.2 0.275 0.434 0.379 3.57 0.595 8.9 1.21 7.13 0.344 0.078 0.311 0.669 1.17 1.85 3.17 2.44 2.06
Average
1234
4.72 9.12 6.14 6.29 8.06 6.54 12.06 24.34 140.9 11.89 1.8 25.85 7.12 1.85 2.21 2.8 2.19 1.23 900.2 1.4 2.2 1.92 18.12 3.02 45.21 6.15 36.21 1.75 0.098 0.389 0.836 1.47 2.31 3.97 3.05 2.58
High
1234
18.64 24.61 6.29 12.46 36.26 12.96 43.54 57.12 549.3 40.26 7.02 100.8 27.76 7.2 8.62 10.91 8.52 4.77 3,509 5.45 8.59 7.5 70.64 11.78 176.2 23.99 141.1 6.82 0.117 0.467 1 1.76 2.77 4.76 3.66 3.09
Estimated EBITDA
Low
1234
-11.63 -15.35 -3.92 -7.77 -22.62 -8.08 -27.16 -143 -135.7 -237.9 -178.7 -153 -145.1 -188 -191.2 -163.6 -155.2 -148.6 573.9 -128.3 -102.8 -95.08 -58.42 -73.03 -109.9 -14.96 -55.21 -53.77 -45.7 -36.34 -31.36 -35.32 -26.92 -27.99 -27.39 -28.83
Average
1234
-2.94 -5.69 -3.83 -3.92 -5.02 -4.08 -7.52 -119.2 -113.1 -198.2 -148.9 -127.5 -120.9 -156.7 -159.3 -136.4 -129.4 -123.9 717.4 -106.9 -85.67 -79.24 -48.69 -60.86 -28.2 -3.84 -46.01 -44.81 -38.08 -30.28 -26.13 -29.43 -22.43 -23.32 -22.83 -24.02
High
1234
-0.368 -0.755 -3.74 -0.418 -0.437 -0.475 -0.269 -95.36 -90.47 -158.6 -119.2 -102 -96.76 -125.4 -127.4 -109.1 -103.5 -99.1 860.8 -85.51 -68.54 -63.39 -38.95 -48.69 -5.55 -0.756 -36.81 -35.85 -30.46 -24.23 -20.91 -23.55 -17.95 -18.66 -18.26 -19.22
Estimated EBIT
Low
1234
-11.9 -15.71 -4.02 -7.96 -23.15 -8.27 -27.8 -148.4 -144.1 -250.4 -189.9 -158.8 -154.1 -197.9 -203.1 -169.8 -164.8 -156.4 570.6 -133.7 -105.9 -97.72 -61.15 -79.89 22.22 -15.31 -57.92 -54.81 -44.53 -36.15 -31.25 -34.81 -27.34 -28.04 -27.75 -29.15
Average
1234
-3.01 -5.82 -3.92 -4.02 -5.14 -4.18 -7.7 -123.7 -120.1 -208.6 -158.3 -132.3 -128.4 -164.9 -169.3 -141.5 -137.3 -130.4 713.2 -111.4 -88.25 -81.44 -50.96 -66.58 27.77 -3.93 -48.26 -45.67 -37.11 -30.13 -26.04 -29.01 -22.78 -23.37 -23.12 -24.29
High
1234
-0.377 -0.772 -3.82 -0.428 -0.447 -0.486 -0.275 -98.96 -96.04 -166.9 -126.6 -105.8 -102.7 -131.9 -135.4 -113.2 -109.9 -104.3 855.9 -89.14 -70.6 -65.15 -40.77 -53.26 33.33 -0.773 -38.61 -36.54 -29.69 -24.1 -20.83 -23.21 -18.23 -18.69 -18.5 -19.43
Estimated Net Income
Low
1234
-145.9 -168.8 -162.8 -138.5 -184 -172.1 -163.8 -151.2 -139.7 -247.1 -192.6 -161.7 -149.4 -195.3 -206 -172.9 -159.8 -154.4 568.1 -132.1 -105.2 -97.77 -60.37 -75.71 61.78 451.1 -56.56 -54.79 -46.86 -37.09 -32.17 -36.49 -28.66 -29.37 -28.73 -29.31
Average
1234
-106.2 -115.5 -128 -113.5 -109.6 -128.6 -130.3 -126 -116.4 -205.9 -160.5 -134.7 -124.5 -162.8 -171.7 -144.1 -133.1 -128.7 710.1 -110.1 -87.65 -81.47 -50.31 -63.09 77.23 563.9 -47.14 -45.66 -39.05 -30.91 -26.81 -30.41 -23.88 -24.47 -23.94 -24.43
High
1234
-74.79 -83.97 -85.07 -82.94 -70.54 -38.94 -92.61 -100.8 -93.11 -164.7 -128.4 -107.8 -99.58 -130.2 -137.3 -115.3 -106.5 -102.9 852.1 -88.07 -70.12 -65.18 -40.25 -50.47 92.67 676.7 -37.71 -36.53 -31.24 -24.73 -21.44 -24.33 -19.11 -19.58 -19.15 -19.54
Estimated SGA Expenses
Low
1234
42.08 86.31 427.3 47.8 49.92 54.29 30.75 15.76 15.9 5.33 25.27 16.85 100 25.94 31.07 39.32 30.69 17.2 22.3 19.63 30.94 27.01 10.79 42.44 34.94 86.42 11.07 24.57 5.56 22.22 47.7 83.75 131.8 226.3 174.2 147
Average
1234
336.6 650.7 438 448.8 574.6 466.6 860 19.7 19.88 848.1 128.4 21.07 508.1 131.8 157.8 199.8 155.9 87.38 27.88 99.72 157.2 137.2 13.49 215.6 43.67 439 13.84 124.8 6.96 27.77 59.63 104.7 164.8 282.9 217.8 183.7
High
1234
1,330 1,755 448.7 889 2,587 924.4 3,106 23.64 23.86 2,872 500.4 25.28 1,981 513.6 615.1 778.6 607.6 340.6 33.45 388.7 612.6 534.7 16.18 840.3 52.41 1,711 16.61 486.6 8.35 33.33 71.55 125.6 197.7 339.5 261.4 220.4
Estimated EPS
Low
1234
-1.6 -1.85 -1.78 -1.52 -2.01 -1.88 -1.79 -1.73 -0.084 -2.08 -10.14 -8.3 -10.73 -10.86 -10.57 -9.24 -8.41 -8.36 -0.155 -7.02 -6.07 -5.65 -4.53 -5.03 -2.69 -2.18 -1.08 -4.25 -0.77 -0.54 -0.53 -0.86 -0.7 -0.82 -0.82 -1.44
Average
1234
-1.16 -1.26 -1.4 -1.24 -1.2 -1.41 -1.43 -1.36 0.066 -1.99 -2.13 -1.74 -2.25 -2.28 -2.22 -1.94 -1.76 -1.75 3.52 -1.47 -1.27 -1.18 -0.951 -1.06 -0.564 -0.457 -0.226 -0.892 -0.64 -0.45 -0.44 -0.72 -0.58 -0.68 -0.68 -1.2
High
1234
-0.819 -0.92 -0.932 -0.908 -0.773 -0.426 -1.01 -0.993 0.204 -0.64 0.094 0.077 0.099 0.1 0.098 0.086 0.078 0.077 16.79 0.065 0.056 0.052 0.042 0.047 0.025 0.02 0.01 0.039 -0.51 -0.36 -0.35 -0.58 -0.46 -0.54 -0.54 -0.96
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us
Want to become our sponsor?
Check out our Affiliate Program